恆指午後跌幅擴至逾900點失26,400 騰訊、藥明、美團及海底撈挫逾7%-18%
工信部啟動互聯網行業專項整治行動，加上國務院指內地學科類培訓機構一律不得上市融資，嚴禁資本化運作。中港股市今天大幅跑輸歐美及亞太區市場，上證及滬深300午後跌幅擴大，最低見3,424及4,859，現造3,458及4,915，續跌2.6%及3.4%；深成見14,376，現造14,601，跌幅擴至2.8%。港股午後跌幅也進一步擴大，其中恆指午後跌幅進一步擴至962點，最低見26,359，現造26,398，急瀉923點或3.4%，成交額1,783億元。
藍籌股普遍捱沽，市監局要求騰訊(00700.HK)30天內解除網絡音樂獨家版權，該股今天跌破500元大關，午後低見489.2元，創逾一年低，現造491.4元，續挫7.5%；阿里巴巴(09988.HK)續挫5.7%報193.6元，暫守穩7月9日盤中所創52周低位189.9元。美團(03690.HK)及海底撈(06862.HK)午後低見245.2元及33元，分別創九個月及逾一年低，現造245.6元及34元，續挫10%及18%。
金融股以國壽(02628.HK)、港交所(00388.HK)及中國平安(02318.HK)沽壓最大，股價續跌逾3%-4.5%，分別低見13.12元、498.6元及67.75元。
憂慮內地未來加強監管行業或延伸至醫藥業，A股醫藥及醫療器械今天下挫，本港相關股以過去累積升幅較大的藥明生物(02269.HK)沽壓最大，股價失守50天線(126.7元)後，跌幅擴大，午後低見116.2元，現造119.4元，續挫8%，中生(01177.HK)續挫5%報6.64元創逾七個月低；非藍籌綠葉製藥(02186.HK)、信達生物(01801.HK)、復星醫藥(02196.HK)及石四藥(02005.HK)也挫逾7.5%-9%。啟明醫療(02500.HK)、永勝醫療(1612.HK)及愛康醫療(01789.HK)也急挫13%-21%，後者最傷曾低見10.2元創逾三個月低。
非藍籌教育股全面遭拋售，尤其是華夏視聽教育(01981.HK)、宇華教育(06169.HK)、中教(00839.HK)、天立教育(01773.HK)、新東方在線(01797.HK)、新東方(09901.HK)、卓越教育(03978.HK)及思考樂教育(01769.HK)急挫逾19%-42%，後三者最傷急挫38%-42%，分別低見18元、0.63元及1.31元。
不過，部分藍籌逆市造好，尤其是長和(00001.HK)、公用股煤氣(00003.HK)、中電(00002.HK)、電能(00006.HK)、長建(01038.HK)、港鐵(00066.HK)、恆隆地產(00101.HK)、吉利(00175.HK)及恆生(00011.HK)逆升逾1%；中銀(02388.HK)、長實(01113.HK)、領展(00823.HK)、、九倉置業(01997.HK)及中信股份(00267.HK)也升近0.5%-0.9%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
